iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IBB iShares Biotechnology ETF

Market Closed 05-10 16:00:00 EDT

133.40

-0.02

-0.01%

盘后133.40

+0.000.00%

17:59 EDT

High134.67	Low133.18	Vol1.08M
Open133.82	D1 Closing133.42	Amplitude1.12%
Mkt Cap7.00B	Tradable Cap7.00B	Total Shares52.50M
T/O144.76M	T/O Rate2.06%	Tradable Shares52.50M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":133.4,"timestamp":1715371200000,"preClose":133.42,"halted":0,"volume":1083431,"hourTrading":{"tag":"盘后","latestPrice":133.4,"preClose":133.4,"latestTime":"17:59 EDT","volume":6066,"amount":809192.4,"timestamp":1715378396761},"delay":0,"floatShares":52500000,"shares":52500000,"eps":6.311863,"marketStatus":"Market Closed","change":-0.02,"latestTime":"05-10 16:00:00 EDT","open":133.82,"high":134.67,"low":133.175,"amount":144764659.08097002,"amplitude":0.011205,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715587200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":133.42,"sharesOutstanding":52500000,"nav":133.404,"aum":7003707740.4,"dividendRate":0.002439,"bidAskSpread":0.000161,"preHourTrading":{"tag":"盘前","latestPrice":134,"preClose":133.42,"latestTime":"09:21 EDT","volume":316,"amount":42284.67416,"timestamp":1715347311562},"postHourTrading":{"tag":"盘后","latestPrice":133.4,"preClose":133.4,"latestTime":"17:59 EDT","volume":6066,"amount":809192.4,"timestamp":1715378396761},"volumeRatio":0.7303555221004782},"requestUrl":"/m/hq/s/IBB","defaultTab":"news","newsList":[{"id":"2433786984","title":"S&P 500's Best 3-Day Run in 2024: ETF Areas That Won","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786984","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2433786984?lang=en_us&edition=fundamental","pubTime":"2024-05-07 20:00","pubTimestamp":1715083200,"startTime":"0","endTime":"0","summary":"Wall Street was in great shape on Monday, with the S&P 500 experiencing its largest three-day rally of the year, fueled by anticipations of Federal Reserve rate cuts in 2024 and upbeat earnings as well as guidance and analysts’ estimates. The S&P 500 increased by 3.23% and the tech-focused Nasdaq Composite advanced by 4.8%. The Dow Jones Industrial Average saw a 2.5% rise.On May 6, 2024, Tom Barkin, President of the Richmond Federal Reserve, commented that the current interest rates should be enough to gradually reduce inflation to the Fed's target of 2%. Per Barkin, \"the economy is moving toward better balance, but no one wants inflation to reemerge.\". In addition, John Williams, President of the Federal Reserve Bank of New York, stated that any decisions on rate cuts would be based on a comprehensive review of economic data, but noted that the current monetary policy is \"in a very good place.\". According to the CME FedWatch Tool, over two-thirds of wagers now predict a rate cut from ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7U81L95SEaqHrdpCbdkxSg--~B/aD00MTQ7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e355dece32180ff77ef1c88a91255c16","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7U81L95SEaqHrdpCbdkxSg--~B/aD00MTQ7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e355dece32180ff77ef1c88a91255c16"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/p-500s-best-3-day-120000054.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433201222","title":"BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2433201222","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433201222?lang=en_us&edition=fundamental","pubTime":"2024-05-07 12:59","pubTimestamp":1715057940,"startTime":"0","endTime":"0","summary":"“Hot Company Multi-Factor Authentication” Award Winner in 12th Annual Global InfoSec Awards at #RSAC 2024HOLMDEL, N.J. and SAN FRANCISCO, May  07, 2024  (GLOBE NEWSWIRE) -- BIO-key International, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/07/2876767/0/en/BIO-key-Wins-Coveted-Global-InfoSec-Award-for-Multi-factor-Authentication-During-RSA-Conference-2024.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432587478","title":"Sector Update: Health Care Stocks Mixed Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2432587478","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2432587478?lang=en_us&edition=fundamental","pubTime":"2024-05-01 03:58","pubTimestamp":1714507105,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed late Tuesday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund  little changed, erasing earlier gains.In corporate news, the Federal Trade Commission sent warning letters to 10 companies and notified the Food and Drug Administration that it disputes the accuracy or relevance of more than 300 patent listings across 20 different brand name products in the FDA's Orange Book. The FTC's challenges include patent listings for Novo Nordisk's  Ozempic, Victoza, and Saxenda. Novo Nordisk shares rose 1.2%.GeneDx  reported late Monday that its Q1 adjusted net loss narrowed following a surge in revenue. TD Cowen adjusted the company's price target to $24 from $14 while keeping its buy rating. Its shares surged almost 60%.Eli Lilly  lifted its full-year outlook after delivering higher Q1 results on a yearly basis, boosted by sales of the company's Mounjaro diabetes drug and weight-loss drug Zepbound. Its shares jumped 6%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-mixed-195825624.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431349741","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of FOMC Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2431349741","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2431349741?lang=en_us&edition=fundamental","pubTime":"2024-04-30 20:13","pubTimestamp":1714479216,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust  slipped 0.1% and the actively traded Invesco QQQ Trust  was 0.2% lower in Tuesday's premarket activity, ahead of the Federal Open Market Committee's policy meeting slated to begin later in the day.US stock futures were also lower, with S&P 500 Index futures edging down 0.1%, Dow Jones Industrial Average futures slipping 0.1%, and Nasdaq futures also losing 0.1% before the start of regular trading.The Q1 employment cost index will be released at 8:30 am ET, followed by the Case-Shiller Home Price Index for February, and the FHFA House Price Index for February, both at 9 am ET.The Chicago PMI posts at 9:45 am ET, while the April Consumer Confidence report from The Conference Board will be released at 10 am ET.In premarket action, bitcoin was down by 2.9% and the cryptocurrency fund ProShares Bitcoin Strategy ETF  was 3.2% lower.Technology Select Sector SPDR Fund  retreated 0.1%, and the iShares US Technology ETF  was inactive,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exchange-traded-funds-equity-futures-121336519.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431826548","title":"Sector Update: Health Care Stocks Edge Higher Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2431826548","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2431826548?lang=en_us&edition=fundamental","pubTime":"2024-04-30 03:55","pubTimestamp":1714420546,"startTime":"0","endTime":"0","summary":"Health care stocks were advancing late Monday afternoon, with the NYSE Health Care Index fractionally up and the Health Care Select Sector SPDR Fund  0.1% higher.In corporate news, Addex Therapeutics  shares plunged 53% after the company said adjunctive administration of its investigational drug ADX71149 with levetiracetam or brivaracetam did not meet the primary goal of the phase 2 study.Deciphera Pharmaceuticals  on Monday agreed to be acquired by Japan's ONO Pharmaceutical through a tender offer in a deal worth about $2.4 billion. Deciphera shares soared 72%.Sight Sciences  said Monday it has received a jury trial verdict of $34 million related to the patent-infringement lawsuit it filed in September 2021 against Alcon  in the US District Court for the District of Delaware. Sight Sciences shares jumped almost 10%.Annovis Bio  sank 59% after the company's phase 2/3 study of buntanetap to treat mild to moderate Alzheimer's disease missed an efficacy endpoint \"due to the limited number","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-edge-195546950.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430973541","title":"Sector Update: Health Care Stocks Edge Higher Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2430973541","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2430973541?lang=en_us&edition=fundamental","pubTime":"2024-04-27 03:57","pubTimestamp":1714161434,"startTime":"0","endTime":"0","summary":"Health care stocks were advancing late Friday afternoon, with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund  up 0.1%.In corporate news, PTC Therapeutics  shares jumped 13%, a day after the company posted Q1 results topping consensus estimates.Pfizer  said Friday the US Food and Drug Administration has approved Beqvez to treat hemophilia B, a rare genetic bleeding disorder, in adult patients. Its shares added 0.8%.ResMed  shares surged 19% after the company reported fiscal Q3 non-GAAP earnings of $2.13 per diluted share, up from $1.68 a year earlier. Analysts surveyed by Capital IQ expected $1.91.Biodexa Pharmaceuticals  soared 73% after it said Friday it has signed a deal with Emtora Biosciences for the exclusive, global rights for eRapa, a phase 3-ready drug to treat familial adenomatous polyposis, an inherited disease that affects the gastrointestinal tract.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-edge-195714791.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429045301","title":"BUZZ Investing: CPI Surge Spikes Bond Yields","url":"https://stock-news.laohu8.com/highlight/detail?id=2429045301","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429045301?lang=en_us&edition=fundamental","pubTime":"2024-04-24 21:05","pubTimestamp":1713963900,"startTime":"0","endTime":"0","summary":"The BUZZ NextGen AI US Sentiment Leaders Index returned 5.39% during the month of March, compared to a return of 3.22% for the S&P 500 Index during the same period.Shares of Coinbase Global Inc. led g","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2129336276/image_2129336276.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2129336276/image_2129336276.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4685632-buzz-investing-cpi-surge-spikes-bond-yields","is_publish_highlight":false,"gpt_icon":1},{"id":"2429901509","title":"Sector Update: Health Care Stocks Increase Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2429901509","media":"MT Newswires","top":-1,"share":"https://ttm.financial/m/news/2429901509?lang=en_us&edition=fundamental","pubTime":"2024-04-23 03:56","pubTimestamp":1713815785,"startTime":"0","endTime":"0","summary":"Health care stocks were advancing late Monday afternoon with the NYSE Health Care Index adding 0.6% and the Health Care Select Sector SPDR Fund  up 0.5%.In corporate news, Hepion Pharmaceuticals  said late Friday that it has started wind-down activities in its phase 2b ASCEND-NASH trial of rencofilstat, while continuing to explore strategic alternatives. Its shares plunged 31.7%.Moolec Science  shares surged more than 68% after it said Monday that the Animal and Plant Health Inspection Service of the US Department of Agriculture has determined that the company's modified soybean is not subject to regulations for the movement of genetically engineered organisms.Cardinal Health  said it will not renew its pharmaceutical distribution contracts with OptumRx, which will expire at the end of June. Cardinal shares tumbled 5%.Guardant Health  said Monday that a panel of the US Food and Drug Administration Medical Devices Advisory Committee will review the premarket approval application for its","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-increase-195625114.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429905906","title":"BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2429905906","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2429905906?lang=en_us&edition=fundamental","pubTime":"2024-04-22 20:30","pubTimestamp":1713789000,"startTime":"0","endTime":"0","summary":"HOLMDEL, N.J., April  22, 2024  (GLOBE NEWSWIRE) -- BIO-key International, Inc.(Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/22/2867239/0/en/BIO-key-International-Inc-Receives-Notice-of-Non-Compliance-from-Nasdaq.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426441221","title":"Top 10 best performing S&P 500 health care stocks of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2426441221","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426441221?lang=en_us&edition=fundamental","pubTime":"2024-04-11 02:56","pubTimestamp":1712775367,"startTime":"0","endTime":"0","summary":"Wall Street's latest downward push Wednesday has many investors thinking of getting defensive in their portfolios. One of the more defensive sectors investors can look at is health care, which traditi","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1448453929/image_1448453929.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1448453929/image_1448453929.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4088691-top-10-best-performing-sp-500-health-care-stocks-of-2024","is_publish_highlight":false,"gpt_icon":1},{"id":"2426470191","title":"Switzerland’s Canton of Ticino Implements BIO-key’s Multi-Factor Authentication Solution in its Information Systems Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2426470191","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2426470191?lang=en_us&edition=fundamental","pubTime":"2024-04-09 13:15","pubTimestamp":1712639700,"startTime":"0","endTime":"0","summary":"TICINO, Switzerland and HOLMDEL, N.J., April  09, 2024  (GLOBE NEWSWIRE) -- BIO-key International, Inc.(NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/09/2860088/0/en/Switzerland-s-Canton-of-Ticino-Implements-BIO-key-s-Multi-Factor-Authentication-Solution-in-its-Information-Systems-Center.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424811023","title":"Rare Stock Picks In March 2024 - From 24 Discerning Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2424811023","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424811023?lang=en_us&edition=fundamental","pubTime":"2024-04-03 20:00","pubTimestamp":1712145600,"startTime":"0","endTime":"0","summary":"Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting March 2024 investment picks you may have missed.As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ideas hard to come by in today's market environment.The following new investment ideas were made by analysts who have NO OTHER Buy/Strong Buy recommendations in the past 3 months, making them rare selections. The rally we noted last month, and the month before, continued in March  with the S&P up ~3%. Are there any compelling investment ideas out there that may have flown under your radar?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4681746-rare-stock-picks-in-march-2024-from-24-discerning-analysts","is_publish_highlight":false,"gpt_icon":1},{"id":"2424070729","title":"5 Healthcare Stocks to Buy for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2424070729","media":"InvestorPlace","top":-1,"share":"https://ttm.financial/m/news/2424070729?lang=en_us&edition=fundamental","pubTime":"2024-04-03 04:30","pubTimestamp":1712089804,"startTime":"0","endTime":"0","summary":"Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/04/5-healthcare-stocks-to-buy-for-2024/","is_publish_highlight":false,"gpt_icon":0},{"id":"2424169741","title":"PBE: Biotech Could Be Next Big Winner","url":"https://stock-news.laohu8.com/highlight/detail?id=2424169741","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424169741?lang=en_us&edition=fundamental","pubTime":"2024-04-01 22:30","pubTimestamp":1711981800,"startTime":"0","endTime":"0","summary":"Biotechnology and genomics sector has not performed well in recent years, making it an attractive investment opportunity.The Invesco Biotechnology & Genome ETF offers comprehensive exposure to the biotech sector with a diversified portfolio.PBE has performed better than some similar ETFs but worse than others, highlighting the importance of stock selection in this sector.anusorn nakdee Investing in the field of biotechnology and genomics can be a profitable venture, especially for investors keen on scientific and technological advancements. The problem?","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1453942652/image_1453942652.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1453942652/image_1453942652.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4681465-pbe-biotech-could-be-next-big-winner","is_publish_highlight":false,"gpt_icon":0},{"id":"2424714918","title":"Zacks Investment Ideas feature highlights: SPDR S&P Biotech ETF, iShares Biotech ETF, Viking Therapeutics and Madrigal Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2424714918","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2424714918?lang=en_us&edition=fundamental","pubTime":"2024-04-01 18:37","pubTimestamp":1711967820,"startTime":"0","endTime":"0","summary":"Chicago, IL – April 1, 2024 – Today, Zacks Investment Ideas feature highlights SPDR S&P Biotech ETF XBI, iShares Biotech ETF IBB, Viking Therapeutics VKTX and Madrigal Pharmaceuticals MDGL.After a strong resurgence in the back half of 2023 and continued momentum into the first quarter of 2024, biotech stocks are back in vogue. “Hawkish” Federal Reserve Policy, a brutal bear market in 2022, and investor preference for big tech stocks have meant underperformance for biotech stocks. However, over the past six months, the SPDR S&P Biotech ETF, the best proxy for the industry, rose 30%, regained the critical 200-day moving average, and has garnered renewed investor attention.Liver disease is an area of the biotech market that many well-known biotech companies have tried","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-103700947.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422613330","title":"Catch The Medical Breakthroughs With The IBB ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=2422613330","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422613330?lang=en_us&edition=fundamental","pubTime":"2024-03-28 14:01","pubTimestamp":1711605676,"startTime":"0","endTime":"0","summary":"IBB tracks the performance of the rapidly advancing biotechnological sector.The need for advanced medical innovations is urgent to challenge serious ailments.The fund could benefit investors with up t","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1585552994/image_1585552994.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1585552994/image_1585552994.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4680906-catch-the-medical-breakthroughs-with-the-ibb-etf","is_publish_highlight":false,"gpt_icon":0},{"id":"2422668627","title":"IBB: Let It Rest","url":"https://stock-news.laohu8.com/highlight/detail?id=2422668627","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422668627?lang=en_us&edition=fundamental","pubTime":"2024-03-26 16:46","pubTimestamp":1711442790,"startTime":"0","endTime":"0","summary":"The iShares Biotechnology ETF has underperformed the broader market and remains in the range set last year.Heavily weighted top 10 stocks have flat revenues are are no longer growth stocks.Further ups","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1500368452/image_1500368452.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1500368452/image_1500368452.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4680410-ibb-etf-upside-seems-limited","is_publish_highlight":false,"gpt_icon":0},{"id":"2422633639","title":"This Vaccine Maker Sits on Cash Almost Equal to Its Market Value -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2422633639","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2422633639?lang=en_us&edition=fundamental","pubTime":"2024-03-26 13:00","pubTimestamp":1711429200,"startTime":"0","endTime":"0","summary":"This biotechnology company has nearly 90% of its market value in cash and investments but is being shunned by investors even as they gravitate to the sector this year.The company is BioNTech . It partnered with Pfizer to produce the leading Covid vaccine, Comirnaty, whose original messenger RNA technology was developed by BioNTech. It is rare to find any sizable company with so much cash relative to its market cap.That could offer an opportunity for investors because investors effectively are ascribing little value to the company's Covid vaccine franchise and a drug pipeline geared toward cancer treatments.A large stock buyback program, a payout of a chunk of that cash to investors, potential activist pressure to rein in expenses or distribute the cash or a sale of the company in what has become a more frothy market for biotech companies.The company's 2023 sales were below the Street estimate and its 2024 revenue projection of about $3 billion  was $300 million below","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.0118},{"period":"3month","weight":-0.0088},{"period":"6month","weight":0.1547},{"period":"1year","weight":0.0228},{"period":"ytd","weight":-0.018}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.6875,"avgChangeRate":0.017092},{"month":2,"riseRate":0.625,"avgChangeRate":-0.001732},{"month":3,"riseRate":0.625,"avgChangeRate":0.009624},{"month":4,"riseRate":0.5625,"avgChangeRate":0.004798},{"month":5,"riseRate":0.625,"avgChangeRate":0.01111},{"month":6,"riseRate":0.733333,"avgChangeRate":0.021761},{"month":7,"riseRate":0.733333,"avgChangeRate":0.03561},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003618},{"month":9,"riseRate":0.4,"avgChangeRate":-0.002873},{"month":10,"riseRate":0.375,"avgChangeRate":-0.020602},{"month":11,"riseRate":0.8125,"avgChangeRate":0.039763},{"month":12,"riseRate":0.625,"avgChangeRate":0.014124}],"exchange":"NASDAQ","name":"iShares Biotechnology ETF","nameEN":"iShares Biotechnology ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"iShares Biotechnology ETF,IBB,iShares Biotechnology ETF股票,iShares Biotechnology ETF股票老虎,iShares Biotechnology ETF股票老虎国际,iShares Biotechnology ETF行情,iShares Biotechnology ETF股票行情,iShares Biotechnology ETF股价,iShares Biotechnology ETF股市,iShares Biotechnology ETF股票价格,iShares Biotechnology ETF股票交易,iShares Biotechnology ETF股票购买,iShares Biotechnology ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction